METTL3 may play a carcinogenic role in lung cancer [39], bladder cancer [23, 40], gastric cancer [41], osteosarcoma [42], cutaneous squamous cell carcinoma [43], and acute myeloid leukemia (AML) [44]. Here, METTL3 is linked to cutaneous squamous cell carcinoma.